Aptus Pharma approval is a significant step as BSE grants in-principle backing for ₹44.78 crore preferential issue.
Tag: financial news
Empower India shares: What’s the proven impact of acquisition?
Empower India shares have hit a 5% upper circuit after acquisition news. Discover the implications of this move.
